Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The drug was designed and tested as a single weekly injection, and the clinical trial data supporting its safety and efficacy is based on that dosing pattern
Eventually, she flew to San Diego and crossed the border to Mexico, where a Tijuana clinic offered band removal surgery for a fraction of the price she would have paid in the United States
When you lose muscle, your resting metabolic rate drops
Additionally, in December 2024, Zepbound gained FDA approval for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity
Key highlights: Semaglutide (Novo Nordisk) gaining traction against Tirzepatide (Eli Lilly) Semaglutides market share increased to 21% from 13% in just two months Tirzepatide still holds around 79% share of the GLP-1 segment Indias anti-obesity drug market has tripled to over 1,500 crore in the past year Lower pricing, wider physician adoption, and improved availability are helping Novo Nordisk expand its footprint
